METHOD OF PREPARING CONTROLLED LONG-ACTING PHARMACEUTICAL FORMULATIONS NIT DOSAGE FORM HAVING UNIFORM AND COMPARABLE BIOAVAILABILITY ACTERISTICS

• 1. 具有均匀药物分布和效力的低剂量药物组合物的制备方法 [P] . 中国专利： CN1240375C . 2006.02.08
• 2. 具有均匀药物分布和效力的低剂量药物组合物的制备方法 [P] . 中国专利： CN1531423A . 2004-09-22
• 3. Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics [P] . YU46312B . 1993-05-28

  机译： 具有均匀和可比较的生物利用度特征的单位剂型的受控长效药物制剂的制备方法

• 4. Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics [P] . GR3005851T3 . 1993-06-07

  机译： 具有均匀和可比较的生物利用度特征的单位剂型的受控长效药物制剂的制备方法

• 5. METHOD OF PREPARING CONTROLLED LONG-ACTING PHARMACEUTICAL FORMULATIONS IN UNIT DOSAGE FORM HAVING UNIFORM AND COMPARABLE BIOAVAILABILITY CHARACTERISTICS [P] . CA1297409C . 1992-03-17

  机译： 具有统一和可比较的生物利用度特征的单位剂量形式的可控长效药物制剂的制备方法

• 1. ADDITIVE MANUFACTURING IN PHARMACEUTICAL FORMULATION - DEVELOPMENT OF BIODEGRADABLE PRINTED DOSAGE FORMS FOR ORAL DRUG DELIVERY [C] . Matej Novak, Frantisek Stepanek, Pavel Kovacik Conference on Innovative Materials For Additive Manufacturing . 2020
• 2. Pharmaceutical formulation development utilizing hot melt extrusion and other techniques for development of immediate and controlled release dosage forms. [D] . Mohammed, Noorullah Naqvi. 2012
• 3. Validated Stability-Indicating RP-HPLC Method for the Estimation of Degradation Behaviour of Organic Peroxide and Third-Generation Synthetic Retinoids in Topical Pharmaceutical Dosage Formulation [O] . Chinmoy Roy, Lalatendu Panigrahi, Jitamanyu Chakrabarty 2015
• 4. Development and Validation of Stability-Indicating HPTLC Method for Estimation of Naratriptan Hydrochloride in Its Pharmaceutical Dosage Form and Its Content Uniformity Testing [O] . Pintu B. Prajapati, Jagdish Chotalia, Kunjan B. Bodiwala, 2016

• 1. Validation of HPLC and FIA Spectrophotometric Methods for the Determination of Lansoprazole in Pharmaceutical Dosage Forms and Human Plasma [J] . Idrees F. Al-Momani ,Majdoleen H. Rababah . 美国分析化学（英文） . 2010,第1期
• 2. Square Wave Voltammetric Behavior of N,N-DiethyI-P-Nitroso Aniline an Indirect Method for Determination of Chlorpheniramin Maleate, Application of Pharmaceutical Formulations [J] . Saddalah Tawfeeq Sulaiman ,Mohammed Ameen Abdullah Al-Imam ,Anfal Raad Mahmood . 化学与化工 . 2013,第004期
• 3. Efficacy and Tolerability of Long-Acting Injectable Formulation of Nalmefene (Nalmefene Consta 393.1 mg) for Opioid Relapse Prevention: A Multicentre, Open-Label, Randomised Controlled Trial [J] . Sead Kadric ,Hanns Mohler ,Olli Kallioniemi . 神经科学国际期刊（英文） . 2019,第3期
• 4. A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 mg) for Cocaine Relapse Prevention [J] . Sead Kadric ,Hanns Mohler ,Olli Kallioniemi . 神经科学国际期刊（英文） . 2019,第3期
• 5. Simultaneous Determination of N-Acetyl Cysteine and Taurine by HPTLC Method in Active Pharmaceutical Ingredient and Pharmaceutical Dosage Form [J] . A. R. Magesh ,Magharla Dasaratha Dhanaraju . 美国分析化学（英文） . 2017,第11期
• 6. 抗结核药物固定剂量复合剂生物利用度研究进展 [C] . 于杰 ,李妍妍 ,韩文忠 . 第六届沈阳科学学术年会 . 2009
• 7. 通过RAFT聚合可控制备具有光热效应的高分子纳米复合材料及其在药物释放中的应用研究 [A] . 张爱堂 . 2018